Treatment of multiple sclerosis by oral administration of autoan

Details Treatment of multiple sclerosis by oral administration of autoan Treatment of multiple sclerosis by oral administration of autoan

1995-05-31

1999-02-09

Achutamurthy, Ponnathapura

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

424451, 424464, 514 2, 514 12, 514 21, 514903, A61K 3900

Patent

active

058690549

ABSTRACT:
The invention is directed to a method of treating a T cell-mediated autoimmune disease in animals, including humans, by the oral or enteral administration of autoantigens, fragments of autoantigens, or analogs structurally related to those autoantigens, which are specific for the particular autoimmune disease. The method of the invention includes both prophylactic and therapeutic measures.

REFERENCES:
patent: 4804745 (1989-02-01), Koepff et al.
patent: 5075112 (1991-12-01), Lane
.tangle-solidup. Allegretta, M., et al., Science, 247:718-721, 1990.
.diamond-solid. Avrilionis, K. and Boggs, J.M., J. Neuroimmunol. 35:210-10, 1991.
.tangle-solidup. Ben-Nun, A., et al., J. Immunol., 129:303-308, 1982.
Bitar et al., Cell. Immun., 122:364-370, 1988.
.diamond-solid. Burns, F.R., et al., J. Exp. Med., 169:27-39, 1989.
.tangle-solidup. Chen et al., Science 265:1237, 1994.
+ Cremer, et al., J. Immunol. 87:2995, 1983.
.tangle-soliddn. Eisenbarth, G.S., New Eng. J. Med. 314:1360-8, 1986.
+ Englert, et al., Cell. Immunol. 87:357, 1984.
.diamond-solid. Gaur et al., Science 258:1491-4, 1992.
.tangle-soliddn. Harrison et al., J. Clin. Invest. 89:1161-5, 1992.
.diamond-solid. Holoshitz, J. et al, J. Immunol. 131:2810, 1983.
.tangle-solidup. Howell, M.D., et al., Science, 246:668-670, 1989.
Janeway, Nature 341:482-83, 1989.
.tangle-solidup. Khoury, S. J., et al., J. Exp. Med. 176:1355, 1992.
+ Lane, I. William et al., Sharks Don't Get Cancer, Avery Publishing Group Inc., 1992, updated edition 1993.
.tangle-solidup. Lider et al., Ann. N. Y. Acad. Sci., pp. 267-273, 1986.
.diamond-solid. Martin, R., et al., J. Immunol. 145:540-8, 1990.
.tangle-solidup. Martin, R., et al., J. of Exper. Med. 173:19-24, 1991.
.tangle-solidup. Martin, R., et al., J. Immunol. 148:1359-1366, 1992.
.tangle-solidup. Miller, A., et al., J. Exp. Med. 174:791, 1991.
.tangle-solidup. Miller, A., et al., Proc. Natl. Acad. Sci. USA 89:421, 1992.
.diamond-solid. Miller, A., et al., J. Immunol. 151:7307-15, 1993.
.diamond-solid. Miller, A., et al., J. Neuroimmunol. 46:73-82, 1993.
.tangle-soliddn. Mori, et al., Diabetologia 29:244-7, 1986.
.smallcircle. Nussenblatt, R. B. et al., J. Immunol. 144:1689, 1990.
.diamond-solid. Ota, K, et al., Nature, 346:183-7, 1990.
.diamond-solid. Pette, M., et al., Proc. Natl. Acad. Sci., USA 87:7968-72, 1990.
+ Pinals, R. S., et al., Arthritis Rheum. 24:1308, 1981.
+ Rama, et al., Conncective Tissue Research 12:111, 1984.
.tangle-solidup. Santos, L. M. B., et al., J. Immunol. 150:115A, 1993.
Schwartz, Ann. Rev. Immunol. 3:237-61, 1985.
+ Sewel, K.L. and Trentham, D.E., The Lancet 341:283, 1993.
+ Steinbrocker, O., et al., JAMA 140:659, 1949.
.diamond-solid. Su, X., et al., J. Neuroimmunol. 34:181-190, 1991.
+ Trentham, D. E., et al., Science 261:1727, 1993.
.diamond-solid. Vandenbark, A.A., et al., Nature, 341:541-544, 1989.
+ Weinblatt, M.E., et al., N. Eng. J. Med. 312:818, 1985.
.tangle-solidup. Weiner et al., (Abstr) Neurology (Suppl. 1) 39:172, 1989.
.tangle-solidup. Whitacre, C. C., et al., J. Immunol. 147:2155, 1991.
.diamond-solid. Wucherpfenning, K.W. et al., Science 248:1016-9, 1990.
.diamond-solid. Zamvil, S. S., et al., Nature 324:258-260, 1986.
+ Zhang, Z. J., et al., J. Immunol. 145:2489, 1990.
.tangle-soliddn. Zhang, Z. J., et al., Proc. Natl. Acad. Sci. USA 88:10252 1991.
.tangle-solidup. Zhang, Z. J., et al., FASEB J. 6(5) A1693, 1992.
+These references are generally related towards the rheumatoid arthritis claims.
.tangle-soliddn.These references are generally related towards diabetes mellitus claims.
.diamond-solid.These references are particularly relevant to the claims directed towards the use of Myelin Basic Protein fragments.
.tangle-solidup.These references are generally related towards the multiple sclerosis claims.
.smallcircle.These reference are generally related towards other, unclaimed, autoimmune diseases.
AutoImmune Press Release of Apr. 21, 1997.
Higgins et al., J. Immunology, 140:440-445, 1988.
Eylar, Adv. Exp. Med. Bio., 98:259-281, 1978.
Sriram et al., Cell. Immunol., 75:378-382, 1983.
Nagler-Anderson et al., PNAS, 83:7443-7446, 1986.
Scohoen, J. Immunol., 128:717-719, 1982.
Higgins et al., Annals Neurology, abstract No. P154, 1986.
Whitacre et al., 6th Int'l. Cong. Immunol., abstract No. 3.62.21, 1986.
Zamvil et al., Nature, 324:258-260, 1986.
Fritz et al., J. Immunol., 134:2328-2332, 1985.
Fritz et al., J. Immunol., 130:191-194, 1983.
Pettinelli et al., J. Immunol., 129:1209-1211, 1982.
Whitaker et al., J. Bio. Chem, 250:9106-9111, 1975.
Thompson et al., Clin. Exp. Immunol., 64:581-586, 1985.
Lider et al., J. Immunol., 142:748-752, 1989.
Friedman et al., PNAS 91:6688-6692, 1994.
Bitar, dissertation entitled, The Suppressive Effects of Oral Myelin Basic Protein . . . , 1986.
Nagler-Anderson, dissertation entitled, Immunoregulation of an Exp. Model of Autoimmunity, 1986.
Rothbart, 1st Forum in Virology, pp. 518-520, 1986.
Eylar et al., Neurochem. Research, 4:249-258, 1979.
Kagnoff, Oral Tolerance, pp. 248-269, 1982.
Mowat, Immunol. Today, 8:93-98. 1987.
Weiner et al., Science, 259:1321-1324, 1993.
Campbell et al, Arch. Neurol., 29:10-15, 1973.
Carnegie et al., Immunol. 19:55-63, 1970.
Fritz et al., J. Immunol., 130:1024-1026, 1983.
Hashim et al., Arch. Biochem. and Biophy., 156:287-297, 1973.

Affiliated with

Also associated with

Rating

Treatment of multiple sclerosis by oral administration of autoan does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of multiple sclerosis by oral administration of autoan, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of multiple sclerosis by oral administration of autoan will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1946700